Prospect: Information for thepatient
Ciqorin 50 mg Soft Gelatin Capsules EFG
Ciclosporin
Read this prospect carefully before starting to take this medication, as it contains important information for you.
1.What is Ciqorin and how it is used
2.What you need to know before starting to take Ciqorin
3.How to take Ciqorin
4.Adverse effects
5.Storage of Ciqorin
6.Contents of the package and additional information
What is Ciqorin
The name of your medication is Ciqorin. It contains the active ingredient ciclosporina. It belongs to a group of medications known as immunosuppressants. These medications are used to reduce the body's immune reactions.
What Ciqorin is used for and how it works
The recommendations in this prospectus may vary depending on whether you are taking the medication for a transplant or for an autoimmune disease.
Follow all the instructions given by your doctor carefully. They may be different from the general information contained in this prospectus.
Do not take Ciqorin
If this applies to you, do not take Ciqorin and inform your doctor. If you are unsure, consult your doctor before taking Ciqorin.
Warnings and precautions
Inform your doctor immediately before and during treatment with Ciqorin:
If you experience any of the above situations before or during treatment with Ciqorin, inform your doctor immediately.
Sun protection and sunlight
Ciqorin suppresses your immune system. This may increase the risk of developing cancer, particularly skin cancer and lymphatic system cancer. Therefore, you should limit your exposure to the sun and UV rays as follows:
Monitoring during treatment with Ciqorin
Your doctor will monitor:
If you have any questions about how Ciqorin works or why you have been prescribed this medication, consult your doctor.
Additionally, if you are taking Ciqorin for a disease other than a transplant(intermediate or posterior uveitis and Behçet's uveitis, atopic dermatitis, severe rheumatoid arthritis, or nephrotic syndrome), do not take Ciqorin:
If any of these situations apply to you, do not take Ciqorin. If you are unsure, consult your doctor or pharmacist before taking Ciqorin.
If you are being treated for Behçet's uveitis, your doctor will monitor you closely, especially if you experience neurological symptoms (such as frequent forgetfulness, changes in personality observed over time, psychiatric or mood disorders, burning sensations in the extremities, decreased sensitivity in the extremities, tingling sensations in the extremities, weakness in the extremities, motor disorders, headaches with or without nausea and vomiting, visual disorders that include limited eye movements).
Your doctor will monitor you closely if you are an elderly person and are being treated for psoriasis or atopic dermatitis. If you have been prescribed Ciqorin to treat your psoriasis or atopic dermatitis, you should not be exposed to UVB or photochemotherapy during treatment.
Children and adolescents
Ciqorin should not be administered to children for indications other than a transplant, except for the treatment of nephrotic syndrome.
Geriatric population (65 years of age and older)
There is limited experience with Ciqorin in elderly patients. Your doctor should monitor how your kidneys are functioning. If you are over 65 years old and have psoriasis or atopic dermatitis, you should only be treated with Ciqorin if your condition is particularly severe.
Taking Ciqorin with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may take any other medication.
Particularly inform your doctor or pharmacist if you are taking any of the following medications before or during treatment with Ciqorin:
-Medications that can increase the level of ciclosporin in your blood include: antibiotics (such as erythromycin or azithromycin), antifungals (voriconazole, itraconazole), medications used for heart disorders or high blood pressure (diltiazem, nicardipine, verapamil, amiodarone), metoclopramide (used to prevent vomiting), oral contraceptives, danazol (used to treat menstrual disorders), medications used to treat gout (allopurinol), bile acid and derivatives (used to treat gallstones), protease inhibitors used to treat HIV, imatinib (used to treat leukemia or tumors), colchicine, telaprevir (used to treat hepatitis C), cannabidiol (its use includes, among others, the treatment of epilepsy seizures).
-Medications that can decrease the level of ciclosporin in your blood include: barbiturates (used to help you sleep), certain anticonvulsant medications (such as carbamazepine or phenytoin), octreotide (used to treat acromegaly or neuroendocrine tumors in the intestine), tuberculosis medications, orlistat (used to help with weight loss), herbal medications that contain St. John's Wort, ticlopidine (used after a stroke), certain medications that lower blood pressure (bosentan), and terbinafine (an antifungal medication, used to treat infections of the toes and fingernails).
Medications that can affect your kidneys. These include: antibiotics (gentamicin, tobramycin, ciprofloxacin), antifungal medications that contain amphotericin B, medications used to treat urinary tract infections that contain trimethoprim, medications used to treat cancer that contain melphalan, medications used to reduce stomach acid (H2 receptor antagonists), tacrolimus, analgesics (nonsteroidal anti-inflammatory drugs such as diclofenac), bile acid and derivatives (used to reduce fat in the blood).
If any of these situations apply to you (or you are unsure), inform your doctor or pharmacist before taking Ciqorin.
Hepatitis C
Inform your doctor if you have hepatitis C. Your liver function may change with hepatitis C treatment and this may affect the levels of ciclosporin in the blood. Your doctor may need to monitor the levels of ciclosporin in the blood and adjust the dose after starting hepatitis C treatment.
Taking Ciqorin with food and drinks
Do not take Ciqorin with grapefruit or grapefruit juice. This may affect the functioning of Ciqorin.
Consult your doctor or pharmacist before taking this medication. Your doctor will discuss the potential risks of taking Ciqorin during pregnancy.
Driving and operating machinery
You may feel drowsy, disoriented, or have blurred vision after taking ciclosporin. Be careful when driving or operating machinery until you know how it affects you.
Ciqorin contains ethanol
This medicationcontains 79.75 mg of alcohol (ethanol) in each capsule. A dose of 500 mg (797.5 mg of ethanol) is equivalent to less than 20 ml of beer or 8 ml of wine. The small amount of alcohol in this medication will have no noticeable effect.
Ciqorin contains sorbitol
This medication contains 11.03 mg of sorbitol in each capsule.
Ciqorin containshydroxyestearate of macrogolglycerol
It may cause stomach discomfort and diarrhea.
Do not take more than the recommended dose.
Your doctor will carefully adjust the dose of this medication to your individual needs. Taking too much of this medication can affect your kidneys. You will have regular blood tests and hospital visits, especially after the transplant. This will allow you to consult with your doctor about your treatment and any problems you may have.
How much Ciqorin should be taken
Your doctor will indicate the correct dose of Ciqorin for you. This depends on your body weight and the reason you are taking this medication. Your doctor will also inform you how often you should take your medication.
•In adults:
Organ, bone marrow, and stem cell transplant
Endogenous uveitis
Nephrotic syndrome
Severe rheumatoid arthritis
Psoriasis and atopic dermatitis
•In children:
Nephrotic syndrome
Follow exactly the instructions of your doctor and do not change the dose yourself, even if you feel well.
Conversion of cyclosporin to cyclosporin microemulsion
You may have already been taking another oral cyclosporin. Your doctor may decide to switch you to this medication, Ciqorin.
If your doctor switches you from oral cyclosporin to oral cyclosporin microemulsion:
If your doctor switches you from one oral cyclosporin formulation to another
After you switch from one oral cyclosporin formulation to another:
When to take Ciqorin
Take Ciqorin at the same time every day. This is very important if you have had a transplant.
How to take Ciqorin
Your daily dose should always be divided into 2 doses.
Remove the capsules from the blister pack. Swallow the capsules whole with a glass of water.
How long to take Ciqorin
Your doctor will tell you for how long you need to take Ciqorin. This depends on whether you are taking it after a transplant or for the treatment of severe skin diseases, rheumatoid arthritis, uveitis, or nephrotic syndrome. In the case of severe skin eruption, treatment usually lasts 8 weeks.
Continue taking Ciqorin for as long as your doctor tells you to.
If you have any doubts about the use of this medication, ask your doctor or pharmacist.
Some side effects can be serious
Inform your doctor immediatelyif you notice any of the following serious side effects:
Other side effects include:
Very common (may affect more than 1 in 10 people)
If any of them severely affect you, inform your doctor.
Common (may affect up to 1 in 10 people)
If any of them severely affect you, inform your doctor.
Rare (may affect up to 1 in 100 people)
If any of them severely affect you, inform your doctor.
Very rare (may affect up to 1 in 10,000 people)
If this affects you severely,inform your doctor.
Frequency unknown:Cannot be estimated from available data.
If any of them severely affect you, inform your doctor.
Other side effects in children and adolescents
No additional side effects are expected in children and adolescents compared to adults.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus.
You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use, https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and the blister pack after CAD. The expiration date is the last day of the month indicated.
Store below 30°C. Do not freeze. Store in the original packaging to protect it from light and moisture..
Medications should not be disposed of through drains or in the trash. Dispose of containers and medications you no longer need at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of containers and medications you no longer need.By doing so, you will help protect the environment.
Composition of Ciqorin
-The active ingredient is cyclosporin.
-Cada cápsula blanda contiene 50 mg de ciclosporina
-The other components in the capsule content are hydroxyestearateof macrogolglycerol, monolinoleateof glycerol, monoethyl ether of diethyleneglycol, anhydrous ethanol, and D, L-a-tocopherol.
-The other components in the capsule coating are gelatin, glycerol, liquid (non-crystallized) sorbitol (E420), glycine, titanium dioxide (E171), yellow iron oxide (E172), and light liquid paraffin.
Appearance of the product and contents of the package
Ciqorin 50 mg soft capsules are soft gelatin capsules of yellow ochre color that are opaque and contain a colorless to slightly yellowish oily liquid. Approximate size of 20.7 x 7.8 mm.
The capsules are available in package sizes of 20, 30, 50, 50x1,60, 90, and 100 in blisterOPA/Alu/PVC-Aluminum.
Only some package sizes may be commercially available.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Teva Pharma S.L.U.
C/ Anabel Segura 11, Edificio Albatros B, 1st floor
28108 Alcobendas
Madrid, Spain
Responsible manufacturer:
Teva Czech Industries s.r.o.
Ostravska 29, c.p. 305, 74770 Opava-Komarov
Republic of Czech
or
TEVA Pharmaceutical Works Private Limited Company
Pallagi út 13, 4042 Debrecen
Hungary
or
Pharmachemie B.V.
Swensweg 5, 2031 GA Haarlem
Netherlands
or
Merckle GmbH
Ludwig-Merckle-Straße 3, 89143 Blaubeuren
Germany
or
Teva Operations Poland Sp. z.o.o
ul. Mogilska 80. 31-546, Krakow
Poland
This medicine is authorized in the member states of the European Economic Area and in the United Kingdom (Northern Ireland) with the following names:
GermanyCiqorin 50 mg Weichkapseln
SpainCiqorin 50mg soft capsules EFG
ItalyCiqorin
United Kingdom (Northern Ireland)Vanquoral 50 mg Capsules, soft
Last review date of this leaflet: January 2024
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.